New drug combo aims to tame Graft-Versus-Host disease
Disease control
Not yet recruiting
This study tests a new drug called Gecacitinib combined with steroids as the first treatment for moderate to severe graft-versus-host disease (aGVHD) that can occur after a stem cell transplant. The trial will enroll 25 adults who have recently received a transplant and have not …
Phase: PHASE2 • Sponsor: Bin Gu • Aim: Disease control
Last updated May 17, 2026 11:17 UTC